Manulife (Manufacturers Life Insurance)’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
44,441
+379
| +0.9% | +$1.29K | ﹤0.01% | 2654 |
|
|
2025
Q1 | $177K | Sell |
44,062
-1,118
| -2% | -$4.48K | ﹤0.01% | 2528 |
|
|
2024
Q4 | $293K | Sell |
45,180
-1,560
| -3% | -$10.1K | ﹤0.01% | 2460 |
|
|
2024
Q3 | $259K | Sell |
46,740
-17,263
| -27% | -$95.6K | ﹤0.01% | 2549 |
|
|
2024
Q2 | $357K | Buy |
64,003
+2,460
| +4% | +$13.7K | ﹤0.01% | 2340 |
|
|
2024
Q1 | $413K | Buy |
61,543
+1,748
| +3% | +$11.7K | ﹤0.01% | 2274 |
|
|
2023
Q4 | $545K | Sell |
59,795
-739
| -1% | -$6.74K | ﹤0.01% | 2137 |
|
|
2023
Q3 | $334K | Buy |
60,534
+11,251
| +23% | +$62.1K | ﹤0.01% | 2319 |
|
|
2023
Q2 | $421K | Buy |
49,283
+3,126
| +7% | +$26.7K | ﹤0.01% | 2146 |
|
|
2023
Q1 | $424K | Buy |
46,157
+220
| +0.5% | +$2.02K | ﹤0.01% | 2107 |
|
|
2022
Q4 | $469K | Buy |
45,937
+395
| +0.9% | +$4.03K | ﹤0.01% | 2036 |
|
|
2022
Q3 | $670K | Sell |
45,542
-674
| -1% | -$9.92K | ﹤0.01% | 1798 |
|
|
2022
Q2 | $496K | Buy |
46,216
+7,343
| +19% | +$78.8K | ﹤0.01% | 2068 |
|
|
2022
Q1 | $419K | Buy |
38,873
+28,481
| +274% | +$307K | ﹤0.01% | 2302 |
|
|
2021
Q4 | $170 | Buy |
+10,392
| New | +$170 | ﹤0.01% | 2951 |
|